BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30632402)

  • 1. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
    Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
    Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
    Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Exenatide loaded Biotinylated Trimethylated Chitosan/HP- 55 Nanoparticles.
    Guo H; Yan X; Tang H; Zhang X
    Curr Drug Deliv; 2022; 19(1):32-40. PubMed ID: 34126896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
    Zhao X; Li W; Luo Q; Zhang X
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
    Ramalingam P; Ko YT
    Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
    Öztürk AA; Kıyan HT
    Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of temperature-responsive chitosan/hydroxypropyl cellulose blend nanospheres for sustainable flurbiprofen release.
    Işıklan N; Erol ÜH
    Int J Biol Macromol; 2020 Sep; 159():751-762. PubMed ID: 32416307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
    Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
    Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
    Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
    Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Amphotericin B-loaded Trimethyl Chitosan Nanoparticles as a Drug Delivery System and Antifungal Activity on
    Nemati Shizari L; Mohammadpour Dounighi N; Bayat M; Mosavari N
    Arch Razi Inst; 2021; 76(3):571-586. PubMed ID: 34824750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
    Zhang P; Liu X; Hu W; Bai Y; Zhang L
    Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chitosan-graphene oxide blend nanoparticles for controlled flurbiprofen delivery.
    Erol ÜH; Güncüm E; Işıklan N
    Int J Biol Macromol; 2023 Aug; 246():125627. PubMed ID: 37406912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.